Streetbeat News

BDMD

Baird Medical Investment Holdings Limited

https://www.bairdmed.com

Industry

Healthcare

Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Baird Medical (NASDAQ: BDMD) sponsored and participated in the 2024 Guangdong Thyroid Surgery Committee Annual Meeting, highlighting its role in advancing thyroid disease treatment.

Portfolio Pulse from

December 17, 2024 | 1:45 pm

Baird Medical (NASDAQ: BDMD) sponsored an advanced Microwave Ablation (MWA) training session in New Orleans, showcasing its innovative treatment for thyroid nodules, which promises faster recovery times for patients.

Portfolio Pulse from

December 16, 2024 | 2:00 pm

Baird Medical Group (NASDAQ: BDMD) held its 2024 Annual Review and 2025 Planning Meeting, focusing on its strategic vision for 2025. The meeting highlighted the company's achievements and future plans in minimally invasive medical technologies.

Portfolio Pulse from

December 10, 2024 | 2:00 pm

Baird Medical (NASDAQ: BDMD) showcased its microwave ablation technology at the Massachusetts Society of Otolaryngology event, highlighting the trend towards office-based surgical procedures.

Portfolio Pulse from

November 11, 2024 | 1:30 pm

Baird Medical Investment Holdings Limited announced the resignation of CFO Mr. Kun Seng Ng, effective November 1, 2024, with Ms. Jie Li stepping in as acting CFO. The resignation was for personal reasons and not due to any disagreements with the company.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 8:05 pm

In Thursday's pre-market session, several healthcare stocks experienced significant movements. Molecular Templates (MTEM) saw a 96.6% increase, while Elevance Health (ELV) dropped by 12.47% following its Q3 earnings report. Other notable gainers include Klotho Neurosciences (KLTO) and Healthcare Triangle (HCTI), while Biodexa Pharmaceuticals (BDRX) and 180 Life Sciences (ATNF) were among the losers.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 12:10 pm

Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) will showcase its thyroid care innovations at the American Thyroid Association Annual Meeting in Chicago. The company will present its latest microwave ablation technology advancements, highlighting their impact on thyroid treatment.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 9:05 am

Baird Medical Investment shares are trading lower following the release of their preliminary H1 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 4:11 pm

Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) reported a 13.8% increase in H1 2024 revenues to $13.1M and an 85.8% rise in net income to $4.4M. The company, a leading microwave ablation device provider, has expanded into the U.S. market.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:03 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.